BioScrip

Novartis Accused of Paying Kickbacks for Exjade Sales
Bloomberg
Thu, 01/9/14 - 08:28 am
Novartis
Exjade
kickbacks
BioScrip
BioScrip buying CarePoint for $223 million to expand at-home drug infusion business
Yahoo/AP
Tue, 06/18/13 - 08:58 am
CarePoint
BioScrip
M&A
at-home drug infusion